Zimlichman R, Goldstein D S, Eisenhofer G, Stull R, Keiser H R
Clin Exp Pharmacol Physiol. 1986 Nov-Dec;13(11-12):777-81. doi: 10.1111/j.1440-1681.1986.tb02381.x.
Because isoprenaline is not a substrate for neuronal uptake (Uptake-1, U-1), the difference in regional removal of isoprenaline from regional removal of the sympathetic neurotransmitter noradrenaline has been proposed as an index of regional U-1 activity. U-1 activity has not been assessed in the kidney, where decreased U-1 may account for increased renal spillover of noradrenaline into plasma in disorders such as essential hypertension. Tracer-labelled noradrenaline and isoprenaline were simultaneously infused intravenously into anaesthetized dogs, and the regional removal of noradrenaline and isoprenaline was measured in the hindlimb and kidney after administration of the U-1 blocker desipramine, hydrocortisone, which inhibits extra-neuronal uptake of noradrenaline (Uptake-2, U-2), or no drug. Hindlimb removal of noradrenaline (51%) exceeded that of isoprenaline (36%). Desipramine abolished this difference by decreasing removal of noradrenaline without affecting removal of isoprenaline. Renal removal of isoprenaline exceeded that of noradrenaline (74% vs 54%) even after U-1 blockade. Hydrocortisone did not affect removal of noradrenaline or isoprenaline in either bed. The results suggest that differences in removal of noradrenaline and isoprenaline reflect U-1 activity in the hindlimb but not in the kidney; U-1 is much more important than U-2 in the regional removal of noradrenaline; and one mechanism of noradrenaline removal in the kidney is by neuronal uptake.
由于异丙肾上腺素不是神经元摄取(摄取-1,U-1)的底物,因此有人提出,异丙肾上腺素与交感神经递质去甲肾上腺素在区域清除上的差异可作为区域U-1活性的指标。在肾脏中尚未评估U-1活性,在诸如原发性高血压等疾病中,U-1降低可能是导致去甲肾上腺素肾溢入血浆增加的原因。将示踪剂标记的去甲肾上腺素和异丙肾上腺素同时静脉注射到麻醉的狗体内,在给予U-1阻滞剂地昔帕明、抑制去甲肾上腺素非神经元摄取(摄取-2,U-2)的氢化可的松或不给予药物后,测量后肢和肾脏中去甲肾上腺素和异丙肾上腺素的区域清除情况。后肢对去甲肾上腺素的清除率(51%)超过了对异丙肾上腺素的清除率(36%)。地昔帕明通过降低去甲肾上腺素的清除率而不影响异丙肾上腺素的清除率,消除了这种差异。即使在U-1阻断后,肾脏对异丙肾上腺素的清除率仍超过对去甲肾上腺素的清除率(74%对54%)。氢化可的松对任一部位的去甲肾上腺素或异丙肾上腺素的清除均无影响。结果表明,去甲肾上腺素和异丙肾上腺素清除率的差异反映了后肢而非肾脏的U-1活性;在去甲肾上腺素的区域清除中,U-1比U-2重要得多;肾脏中去甲肾上腺素清除的一种机制是通过神经元摄取。